EGFR and breast carcinoma: In addition, in neck and breast carcinoma, EGCG at 30μg/mL EGCG was reported to lower VEGF production in head and neck and breast carcinoma cells by inhibiting epidermal growth factor receptor (EGFR) related pathways [136].